Credit Agricole
TEVA icon

Credit Agricole’s Teva Pharmaceuticals TEVA Stock Holding History

Credit Agricole’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-70,000
Closed -$3.67M – 1621
2014
Q2 		$3.67M Buy
+70,000
New +$3.58M 0.02% 722

Other funds holding TEVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Credit Agricole's TEVA Position: Q1 2026 in Review

Credit Agricole reduced its Teva Pharmaceuticals (TEVA) stake by 5.9% in Q1 2026, selling an estimated $48.6K and leaving 23,956 shares worth $722K. The position accounts for ﹤0.01% of the portfolio, ranked #1136.

Credit Agricole first reported a position in TEVA in Q1 2014 and has held it in 44 quarters since. The position peaked at $67M in Q4 2015. 650 funds tracked by Wall St. Rank hold TEVA as of Q1 2026.

  • Credit Agricole held 23,956 shares of Teva Pharmaceuticals worth $722K as of Q1 2026.
  • Credit Agricole sold 1,512 Teva Pharmaceuticals shares in Q1 2026, an estimated $48.6K.
  • Teva Pharmaceuticals made up ﹤0.01% of Credit Agricole's portfolio in Q1 2026, its #1136 holding.
  • Credit Agricole first reported a position in Teva Pharmaceuticals in Q1 2014 and has held it in 44 quarters since.
  • Credit Agricole's Teva Pharmaceuticals position peaked at $67M in Q4 2015.
  • 650 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2026.

Based on Credit Agricole's 13F filing for Q1 2026, filed 15 May 2026.